Dec 12,2016

MicroTech Completes B Round For Diabetes Devices; Qiming Leads

Qiming Venture Partners led a Series B funding in MicroTech Medical, a Hangzhou diabetes medical device company. The size of the funding round was not disclosed.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 20,2016

Samsung Ventures Invests in Noom, Inc. to Change Behaviors That Cause the Most Pressing Chronic Conditions

Noom, Inc., the world's leading behavior change company, today announced an investment from Samsung Ventures. Noom's platform combines human coaching and artificial intelligence to deliver successful, scalable behavior change programs that prevent and manage chronic conditions.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Dec 20,2016

Indigo Announces Successful Series A Financing Round

Indigo Diabetes, a spin-off from Ghent University and imec, today announces the successful closure of a 7 million Euros series-A financing round. The funding is provided by an international investment syndicate led by Thuja Capital Healthcare Fund II and PMV, and includes Sensinnovat, Parana Management Corp, Qbic Arkiv Fund, Fidimec, SOFI, Manuardeo and Capricorn ICT Arkiv as co-investors. This financing success will fuel the company’s development towards measuring and managing blood glucose levels without the need for finger pricks.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 01,2017

Affordable Point-of-Care Test For Multiple Diseases Being Developed by 1Drop

1Drop — with offices in Boston and in Neuchatel, Switzerland — received a $140,000 grant from the Consortia for Improving Medicine with Innovation & Technology (CIMIT) in 2017 to continue funding the firm's collaboration with Massachusetts General Hospital.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jan 12,2017

Glucose Monitor DarioHealth Raises $5.1M

Israeli digital health and mobile health solutions developer DarioHealth Corp. (formerly Labstyle Innovations) has raised $5.1 million in a private placement. DarioHealth closed on $3.1 million of the transaction while $2 million more of gross proceeds are subject to shareholder approval per Nasdaq rules. The deal was led by OurCrowd Qure, a dedicated digital health fund that invested $2.5 million of the $5.1 million.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Feb 01,2017

Novo Nordisk Partners with Beta Bionics and Invests $5 Million

Beta Bionics shared exclusive breaking news with diaTribe today that it has received an impressive $5 million investment from insulin maker Novo Nordisk in its newest strategic partnership. This very meaningful development will help the Boston-based “public benefit corporation” advance its fully integrated iLet Bionic Pancreas device that automates delivery of insulin and insulin and glucagon (via Dexcom CGM and a smart algorithm).

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 01,2017

Lark Health Raises $20M in Series B

Lark Health, a provider of chronic disease prevention and management programs, closed a $55 million Series C funding round as well as a $15 million venture debt credit facility. The company’s Series A funding round in 2013 raised about $11 million, and its Series B funding round raised approximately $20 million in 2017, Lark Health CEO Julia Hu said.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 06,2017

Cnoga Medical Raises $50M From China’s BOE

Chinese company BOE has invested $50 million in Israeli company Cnoga Medical for 23 percent of the company’s shares, reflecting a company value of $217 million, the two companies reported today.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 08,2017

With $37 million in funding, health startup Virta aims to cure type 2 diabetes by watching what you eat

The company has so far pulled in $37 million in funding from VC firms Venrock, Allen & Company, Ev Williams’ Obvious Ventures, Redmile Group, and PayPal and Affirm founder Max Levchin’s Scifi VC to study new treatment options that could reverse the disorder.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 15,2017

Goodlifeme raises $1.5M to launch its health gaming app in the USA

Goodlifeme, a Swedish-based, Icelandic-founded healthtech company, announced it raised $1.5M in an investment round led by Frumtak Ventures. The money will be used for expanding the business in the United States. Goodlifeme, based in Gothenburg, produces a mobile-based health program, SidekickHealth, and also has a large part of the business operations run through its subsidiary in Iceland. Sidekick Health is a software application that makes use of behavioral economics, game technology and artificial intelligence and is used to identify risk factors and impact on health behavior in order to reduce the prevalence and severity of lifestyle-related diseases such as type 2 diabetes, cardiovascular disease. The app has already some traction in Sweden and Iceland.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING